After an FDA roundtable raised alarms about antidepressant use in pregnancy, physicians warn the rhetoric could fuel fear, stigma, and dangerous gaps in care.
Growing evidence links even low-level PFAS exposure to endocrine disruption, with a new study identifying n-PFOS as a leading driver of risk among women.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The American Cancer Society’s updated cervical cancer screening guideline introduces FDA-approved self-collected HPV testing and clearer exit criteria.
A report on recent federal pronatalist policy initiatives, proposed IVF access measures, and associated government actions involving women’s and children’s health programs in the US.